175 related articles for article (PubMed ID: 23534753)
21. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.
Yao CY; Huang XE; Li C; Shen HB; Shi MQ; Feng JF; Pan LX; Tang JH
Asian Pac J Cancer Prev; 2009; 10(5):859-64. PubMed ID: 20104979
[TBL] [Abstract][Full Text] [Related]
22. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
23. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
[TBL] [Abstract][Full Text] [Related]
24. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.
Chen S; Tang D; Xue K; Xu L; Ma G; Hsu Y; Cho SS
Carcinogenesis; 2002 Aug; 23(8):1321-5. PubMed ID: 12151350
[TBL] [Abstract][Full Text] [Related]
25. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
26. Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.
Syamala VS; Syamala V; Sreedharan H; Raveendran PB; Kuttan R; Ankathil R
Pathol Oncol Res; 2009 Sep; 15(3):389-97. PubMed ID: 19051060
[TBL] [Abstract][Full Text] [Related]
27. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; Selvaggi G; Gregori D; DeMarchi M; Scagliotti GV
Clin Cancer Res; 2007 May; 13(10):2876-81. PubMed ID: 17504986
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population.
Xing D; Qi J; Miao X; Lu W; Tan W; Lin D
Int J Cancer; 2002 Aug; 100(5):600-5. PubMed ID: 12124811
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration.
Görgün E; Güven M; Unal M; Batar B; Güven GS; Yenerel M; Tatlipinar S; Seven M; Yüksel A
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4732-7. PubMed ID: 20375340
[TBL] [Abstract][Full Text] [Related]
31. XRCC1 and XPD gene polymorphisms in a South Indian population.
Vettriselvi V; Vijayalakshmi K; Solomon PF; Venkatachalam P
Asian Pac J Cancer Prev; 2007; 8(2):283-6. PubMed ID: 17696747
[TBL] [Abstract][Full Text] [Related]
32. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.
Rybicki BA; Conti DV; Moreira A; Cicek M; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):23-9. PubMed ID: 14744728
[TBL] [Abstract][Full Text] [Related]
33. Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.
Hussien YM; Gharib AF; Awad HA; Karam RA; Elsawy WH
Mol Biol Rep; 2012 Feb; 39(2):1895-901. PubMed ID: 21643959
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
35. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis.
Chen DQ; Yao DX; Zhao HY; Yang SJ
Asian Pac J Cancer Prev; 2012; 13(6):2791-4. PubMed ID: 22938460
[TBL] [Abstract][Full Text] [Related]
37. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
38. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
40. [Association of the xeroderma pigmentosum group D DNA repair gene with hepatocellular carcinoma].
Zhang JJ; Ma JZ
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):683-7. PubMed ID: 23207233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
